Entera Bio Ltd. IPO Research Information

Entera Bio Ltd. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Entera Bio Ltd. , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Entera Bio Ltd.	ENTX - NASDAQ	$8.00-$10.00	$8.00	$7.30	1.3 million	6/28/2018
Underwriter(s): Maxim Group
Co-Manager(s): Joseph Gunnar
Industry: Health Care
Filing(s): Filed 2017-11-09 Terms Added 2018-01-05 Updated Prospectus 2018-05-18 Updated Terms 2018-06-15

Entera Bio Ltd. Quote & Chart - Click for current quote - ENTX

About Entera Bio Ltd. (adapted from Entera Bio Ltd. prospectus):
They are a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in orphan indications and other areas with significant unmet medical need.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ENTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.